Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Drug

    • Home
    • Drug
    • Page 294
Drug Medical Device

Shanghai Roche Pharmaceuticals Launches Erlotinib for Advanced Non-Small Cell Lung Cancer in China

Fineline Cube Apr 4, 2007

Shanghai Roche Pharmaceuticals Ltd. made headlines in March with the launch of its lung cancer...

Posts pagination

1 … 293 294

Recent updates

  • United Labs TUL108 Gets FDA Nod for Antibiotic Resistance Trial
  • Fosun Pharma Licenses HPV DNA Drug VGX-3100 from ApolloBio for Greater China
  • Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform
  • Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered
  • WuXi Biologics Partners with Sinorda on SND006 Bispecific Antibody for Autoimmune Diseases
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

United Labs TUL108 Gets FDA Nod for Antibiotic Resistance Trial

Company Deals

Fosun Pharma Licenses HPV DNA Drug VGX-3100 from ApolloBio for Greater China

Company Deals

Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform

Company Deals

Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.